These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 20570757)
1. Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. Li F; Wang X; Niyibizi C Bone; 2010 Sep; 47(3):546-55. PubMed ID: 20570757 [TBL] [Abstract][Full Text] [Related]
2. Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model. Pauley P; Matthews BG; Wang L; Dyment NA; Matic I; Rowe DW; Kalajzic I Int Orthop; 2014 Sep; 38(9):1955-62. PubMed ID: 24384938 [TBL] [Abstract][Full Text] [Related]
3. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim). Balk ML; Bray J; Day C; Epperly M; Greenberger J; Evans CH; Niyibizi C Bone; 1997 Jul; 21(1):7-15. PubMed ID: 9213002 [TBL] [Abstract][Full Text] [Related]
4. Engraftment of skeletal progenitor cells by bone-directed transplantation improves osteogenesis imperfecta murine bone phenotype. Sinder BP; Novak S; Wee NKY; Basile M; Maye P; Matthews BG; Kalajzic I Stem Cells; 2020 Apr; 38(4):530-541. PubMed ID: 31859429 [TBL] [Abstract][Full Text] [Related]
5. Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases. Wang X; Li F; Niyibizi C Stem Cells; 2006 Aug; 24(8):1869-78. PubMed ID: 16675597 [TBL] [Abstract][Full Text] [Related]
6. Bone Marrow Transplantation for Treatment of the Col1a2 Lee LR; Peacock L; Ginn SL; Cantrill LC; Cheng TL; Little DG; Munns CF; Schindeler A Calcif Tissue Int; 2019 Apr; 104(4):426-436. PubMed ID: 30535573 [TBL] [Abstract][Full Text] [Related]
7. Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Li F; Wang X; Niyibizi C Stem Cells; 2007 Dec; 25(12):3183-93. PubMed ID: 17823236 [TBL] [Abstract][Full Text] [Related]
8. In vivo expression of human growth hormone by genetically modified murine bone marrow stromal cells and its effect on the cells in vitro. Suzuki K; Oyama M; Faulcon L; Robbins PD; Niyibizi C Cell Transplant; 2000; 9(3):319-27. PubMed ID: 10972331 [TBL] [Abstract][Full Text] [Related]
9. Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Pereira RF; O'Hara MD; Laptev AV; Halford KW; Pollard MD; Class R; Simon D; Livezey K; Prockop DJ Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1142-7. PubMed ID: 9448299 [TBL] [Abstract][Full Text] [Related]
10. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment. Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289 [TBL] [Abstract][Full Text] [Related]
11. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. Oyama M; Tatlock A; Fukuta S; Kavalkovich K; Nishimura K; Johnstone B; Robbins PD; Evans CH; Niyibizi C Gene Ther; 1999 Mar; 6(3):321-9. PubMed ID: 10435082 [TBL] [Abstract][Full Text] [Related]
12. Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties. Vanleene M; Saldanha Z; Cloyd KL; Jell G; Bou-Gharios G; Bassett JH; Williams GR; Fisk NM; Oyen ML; Stevens MM; Guillot PV; Shefelbine SJ Blood; 2011 Jan; 117(3):1053-60. PubMed ID: 21088133 [TBL] [Abstract][Full Text] [Related]
13. Transfer of proalpha2(I) cDNA into cells of a murine model of human Osteogenesis Imperfecta restores synthesis of type I collagen comprised of alpha1(I) and alpha2(I) heterotrimers in vitro and in vivo. Niyibizi C; Smith P; Mi Z; Phillips CL; Robbins P J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):84-91. PubMed ID: 11500956 [TBL] [Abstract][Full Text] [Related]
14. DNA methyltransferases inhibitor azacitidine improves the skeletal phenotype of mild osteogenesis imperfecta by reversing the impaired osteogenesis and excessive osteoclastogenesis. Shao C; Liu Y; Zhao Y; Jing Y; Li J; Lv Z; Fu T; Wang Z; Li G Bone; 2023 May; 170():116706. PubMed ID: 36822490 [TBL] [Abstract][Full Text] [Related]
15. Effects of low-intensity electromagnetic fields on the proliferation and differentiation of cultured mouse bone marrow stromal cells. Zhong C; Zhang X; Xu Z; He R Phys Ther; 2012 Sep; 92(9):1208-19. PubMed ID: 22577063 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta. King D; Jarjoura D; McEwen HA; Askew MJ J Bone Miner Res; 2005 Jun; 20(6):987-93. PubMed ID: 15883639 [TBL] [Abstract][Full Text] [Related]
17. NELL1 promotes high-quality bone regeneration in rat femoral distraction osteogenesis model. Xue J; Peng J; Yuan M; Wang A; Zhang L; Liu S; Fan M; Wang Y; Xu W; Ting K; Zhang X; Lu S Bone; 2011 Mar; 48(3):485-95. PubMed ID: 20959151 [TBL] [Abstract][Full Text] [Related]
18. Origins of endothelial and osteogenic cells in the subcutaneous collagen gel implant. Bilic-Curcic I; Kalajzic Z; Wang L; Rowe DW Bone; 2005 Nov; 37(5):678-87. PubMed ID: 16112632 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional engineered bone from bone marrow stromal cells and their autogenous extracellular matrix. Syed-Picard FN; Larkin LM; Shaw CM; Arruda EM Tissue Eng Part A; 2009 Jan; 15(1):187-95. PubMed ID: 18759662 [TBL] [Abstract][Full Text] [Related]
20. The Role of Bone Marrow-Derived Cells during Ectopic Bone Formation of Mouse Femoral Muscle in GFP Mouse Bone Marrow Transplantation Model. Takabatake K; Tsujigiwa H; Song Y; Matsuda H; Kawai H; Fujii M; Hamada M; Nakano K; Kawakami T; Nagatsuka H Int J Med Sci; 2018; 15(8):748-757. PubMed ID: 30008583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]